MAB OKs AB-Biotics' capital increase

3 November 2011 - Madrid's alternative stock exchange MAB has authorised the capital increase of Spanish biotech AB-Biotics (MCE:ABB).

The company intends to secure between EUR6m (USD8.27m) and EUR8m.

AB-Biotics will place new shares at a price of EUR2.70 apiece. The company will use proceeds to boost its international expansion.

Brokerage house Bankia Bolsa was hired to manage the transaction in cooperation with Mirabaud and Ambers&Co.

(EUR1 = USD1.370)

Published in M2 Pharma on Thursday, 03 November 2011
Copyright (C) 2024, M2 Communications Ltd.

Other Latest Headlines

·Sanofi's Q3 2011 earnings slightly decline to EUR2.4bn (03 Nov 2011 8:40pm)
·Nordiag cuts net loss in Q3 (03 Nov 2011 8:21pm)
·Cryo-Save chairman purchases firm shares, increases stake to 14.1% (03 Nov 2011 8:07pm)
·Procter & Gamble, Teva set up OTC JV (03 Nov 2011 7:18pm)